AYA Artrya Limited
Healthcare · Health Information Services
· website
$3.70
52wk 2.36 – 6.49
Overall
49.4
Value
63.3
Growth
28.6
Health
100.0
Quality
0.0
Momentum
40.4
Dividend
—
Price
About Artrya Limited
Artrya Limited, a medical technology company, engages in the development and commercialization of artificial intelligence platform that detects, diagnoses, and address coronary artery disease in Australia. It offers Salix, a suite of cloud-based software that uses artificial intelligence to automate the detection of coronary artery disease from coronary computed tomography angiography scans to identify and manage patients at risk of a heart attack. The company was incorporated in 2018 and is based in West Perth, Australia.
Price analytics
Returns
| 1 day | 7.9% |
| 1 week | -2.9% |
| 1 month | -11.5% |
| 3 months | -38.1% |
| 6 months | -5.1% |
| 1 year | 54.2% |
| 3 years | 1,581.8% |
Risk
| Volatility (1y ann.) | 83.5% |
| Beta vs ASX 200 | 2.53 |
| Sharpe (1y) | 0.88 |
| VaR 95% (1-day) | -7.5% |
| Max drawdown (1y) | -48.6% |
| Off 1-year high | -41.0% |
Technicals
| RSI(14) | 62 |
| vs 50DMA | -12.2% |
| vs 200DMA | -12.8% |
| Trend | Death cross |
Fundamental trends
Financial statements
Loading…
Scoring breakdown
(2 Oct 2026)
Value
63.3
Trailing P/E
—
Forward P/E
100
PEG ratio
—
EV / EBITDA
100
Price / Book
4
Price / Sales
0
Growth
28.6
Revenue growth (1y)
29
Revenue CAGR (3y)
—
EPS growth (1y)
—
EPS CAGR (3y)
—
Financial Health
100.0
Net debt / EBITDA
—
Interest coverage (EBIT/interest)
—
Current ratio
100
Debt / Equity
100
Quality (Profitability & Cash Flow)
0.0
Return on equity
0
Return on assets
0
Operating margin
0
Net margin
0
Cash conversion (OCF / net income)
—
Dividend / Income
—
No meaningful dividend — pillar excluded from the overall score.
Momentum
40.4
6-month return vs ASX 200
100
Price vs 200-day average
8
Price vs 50-day average
0
Position in 52-week range
32
Hover a row's info icon for the exact rule. Bounds and weights are configurable in the Django admin (Scoring configuration).
Score history
Key metrics
Market cap
$606.21M
P/E (trailing)
—
P/E (forward)
-47.13
EPS (trailing)
-0.17
Dividend yield
—
Payout ratio
0.0%
Beta
0.59
EV / EBITDA
-19.51
Price / Book
7.71
ROE
-50.6%
Operating margin
-114,328.6%
Net margin
0.0%
Total cash
$74.03M
Total debt
$247,000
Current ratio
15.72
Debt / Equity
0.00
Free cash flow
$-11.94M
Avg volume
1.17M
Latest annual results
(FY ending 30 Jun 2026)
- Revenue$28.00K
- Gross profit$28.00K
- Operating income-$33.24M
- Net income-$25.18M
- Diluted EPS—
- Free cash flow-$18.45M
- Net debt-$43.78M